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8PG M E  2-m eth oxy-l-p rop an ol (beta isom er)
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1 I N T R O D U C T I O N
T his docum ent deals w ith the propylene g lyco l ethers m ost com m on ly  used in 
industry, nam ely  m ethoxypropanol, m ethoxypropyl acetate and dipropylene g lyco l 
m onom ethyl ether. B oth  alpha and beta isom ers are present in com m ercial 
m ethoxypropanol and m ethoxypropyl acetate. T hese isom ers d iffer in toxicity  and 
are therefore treated separately.
T he propylene g ly co l ethers are co lorless liquids at room  temperature. T hey  have a 
sw eet, etherlike odor and are com p letely  m iscib le with water and a num ber o f  
organic so lven ts.
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2 PHYSICAL AND CHEMICAL PROPERTIES
2.1 Methoxypropanol, alpha isomer
C hem ical name: l-m e th o x y -2 -p r o p a n o l
C A S number: 1 0 7 -9 8 -2  (alpha isom er)
1 3 2 0 -6 7 -8  (unspecified  isom er)
Synon ym s: propylene g lycol m onom ethyl ether,
propylene g lyco l m ethyl ether, PG M E
M olecular formula: C4H j QO2
Structural formula: C H 3 - O  OH
C H 2 - CH  - C H 3
M olecular weight: 90 .1
B o ilin g  point (101 .3  kPa): 119 .6  °C  (41)
M elting point: -96  °C  (3)
V apor pressure (25°C ): 1.6 kPa (11 .8  m m  H g ) (4 1 )
Saturation concentration (25°C): 15500 ppm (41)
R elative evaporation rate: 0 .7  (47)
(n -b u tyl aceta te= l)
V apor density (25°C , a ir= l): 3 .1 1 ( 4 1 )
Liquid density (25°C /4°C ): 0 .9 1 7  (41)
Flash point: 38°C  (100°F ) (41)
M iscib ility  with w ater OO
C onversion  factors: 1 ppm  =  3 .6 8  m g /m
1 m g/m ^ = 0 .2 7 2  ppm
Propylene g lyco l ethers are com m ercially  prepared by reacting propylene ox id e with  
m ethyl alcohol in the presence o f  a catalyst. T w o  isom ers, often designated by alpha 
( l-m e th o x y -2 -p r o p a n o l)  and beta (2 -m e th o x y -l-p r o p a n o l, BPGM E), are 
obtained. The com m ercial product (PG M E) contains m ainly alpha (9 5 -9 9  %), the 
rem ainder (1 -5  % )  being beta isom er. O ne report, for exam ple, states that 95  %  is
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alpha isom er (12). In another report the manufacturer's declaration o f  9 8 .2  %  alpha 
and 1.8 %  beta isom er w as confirm ed by gas chrom atography - m ass spectrom etry  
(G C -M S ). T he purity w as >  9 9 .9  % (24 ). T he com m ercial product D o w a n o l®
PM  contains at least 9 7 .5  % alpha isom er and no  m ore than 2 .5  % beta isom er, 
according to the manufacturer (3). T he product used in human experim ents 
conducted  by  Stewart e t  a l. (51) w as stated to contain 98  %  PG M E , 0 .4  % w ater  
and 1.6  %  corrosion  inhibitors.
A n  odor threshold for PG M E o f  10 ppm  (3 6  m g /m 3) is g iven  in tw o  reports (1 , 
39). The origin o f  this value m ay be a study in w hich m ale volunteers placed in a 
truck cab in  a controlled exposure situation reported detectable odor at 10  ppm  
PG M E  (51).
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2.2 Methoxypropanol, beta isomer
C hem ical name: 
C A S number:
Synon ym s:
M olecular formula: 
Structural formula:
M olecular weight: 
C onversion factors:
2-m e th o x y - 1 -propanol
not available for beta isom er  
1 3 2 0 -6 7 -8  (unspecified  isom er)
propylene g lyco l m onom ethyl ether, 
propylene g lyco l m ethyl ether, BPGME
C 4 h 1 0 ° 2
OH O - C H 3 
c h 2 - CH  - C H 3
9 0 .1
1 ppm  =  3 .6 8  m g /m 3 
1 m g /m 3 =  0 .2 7 2  ppm
Sm all am ounts (1 -5  % ) o f  the beta isom er 2 -m e th o x y -1-p rop an ol (BPGM E) are 
present in technical m ethoxypropanol, the m ain com ponent o f  w hich is the alpha 
isom er ( l - m e t h o x y - 2-p rop an ol).
There are no data on the odor threshold o f  BPGME.
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2 .3  M ethoxypropyl ace ta te , a lp h a  isom er
C hem ical name: l-m e th o x y -2 -p r o p y l acetate
C A S  number:
S yn on ym s:
M olecular formula: 
Structural formula:
1 0 8 -6 5 -6  (alpha isom er)
8 4 5 4 0 -5 7 -8  (unspecified  isom er)
propylene g lyco l m onom ethyl ether acetate, 
propylene g lycol m ethyl ether acetate, PG M EA
C 6h 1 2 ° 3
O
O -  c - c h 3 
C H 2 - C H  - C H 3
c h 3 - O
M olecular weight: 132.1
B o ilin g  point (1 0 1 .3  kPa): 145 .8°C  (4)
M elting point: <  -67 °C  (4)
V apor pressure (20°C ): 0 .5  kPa (3 .7  m m  H g ) (4)
V apor density (a ir= l): 4 .5 5  (4)
Liquid density: 0 .9 7  (4)
F lash point: 42 .2 °C  (4)
M iscib ility  with w a ter »  19 %  (w /w ) (4)
C onversion  factors: 1 ppm  =  5 .4 0  m g /m 3 
1 m g /m 3 =  0 .1 8 5  ppm
T echnical m ethoxypropyl acetate (PG M E A ) consists m ainly o f  the alpha isom er  
( l-m e th o x y -2 -p r o p y l acetate). In one study it w as stated that the alpha isom er o f  
P G M E A  used w as o f  at least 95  %  purity (28). T he rem ainder is largely  beta 
isom er (2 -m e th o x y - l-p r o p y l acetate, BPG M EA).
T here are no data on the odor threshold o f  PG M E A .
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2.4 Methoxypropyl acetate, beta isomer
C hem ical name: 




M olecular weight: 
C onversion  factors:
2-m e th o x y - l-p r o p y l acetate
7 0 6 5 7 - 7 0 - 4  (beta isom er)
8 4 5 4 0 -5 7 -8  (unspecified  isom er)
propylene g lycol m onom ethyl ether acetate, 
propylene g lyco l m ethyl ether acetate, BPGM EA
c 6h 1 2 ° 3
O
C H 3 - C - 0  O  - c h 3 
C H 2 - CH - C H 3
132.1
1 ppm  = 5 .4 0  m g /m 3 
1 m g /m 3 = 0 .1 8 5  ppm
Sm all am ount o f  the beta isom er 2 -m e th o x y - l-p r o p y l acetate (BPGM EA) are 
present in technical grade m ethoxypropyl acetate.
T here are no data on the odor threshold o f  BPGM EA.
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2 .5  D ipropylene glycol m ethyl e th e r
Chem ical nam e (main isom er): l- (2 -m e th o x y - l-m e th y le th o x y )-2 -p r o p a n o l
(additonal isom ers are g iven  in T able 1)
C A S number:




B o ilin g  point (1 01 .3  kPa): 
M elting point:
V apor pressure (25 °C):
3 4 5 9 0 -9 4 -8  (unspecified  isom er)
dipropylene g lyco l m onom ethyl ether, 
dipropylene glycol m ethyl ether, D P G M E
c 7h 1 6 ° 3
c h 3 - o  c h 3
c h 2 - C H  - O  OH




0 .0 5  kPa (0 .38  m m  H g ) (41)
Saturation concentration (25°C ): 5 1 0  ppm  (41)  
V apor density (a ir^ l): 5 .1 4
Liquid density (25°C /4°C ): 0 .9 4 8  (41 )
Flash point: 
M iscibility  w ith waten
C onversion factors:
85°C  (185°F ) (41)
OO
1 ppm  = 6 .0 6  m g /m 3’
1 m g /m 3 =  0 .1 6 5  ppm
Four structural isom ers can theoretically be form ed in the propylene ox id e  based  
production o f  dipropylene g lyco l m ethyl ether. T he main isom er as w ell as the 
technical product are abbreviated as D PG M E  in this docum ent. There are tw o  
asym m etrical carbon atom s in the m olecu le, hence configurational isom ers m ay also  
ex ist.
Landry and Y ano isolated four isom ers in the com m ercial product D o w a n o l®  D PM  
and w ere able to identify the structure o f  tw o o f  them  (Table 1) (25). The main  
isom er w as a m ixture o f  tw o  enantiom ers constituting 3 5 .4  % and 49.1 % ,
7
respectively . R adiolabelled  D P G M E  containing 9 3 .2  %  o f  the m ain isom er w as  
used in a m etabolic study (30). T he sam e authors found four isom ers in D o w a n o l®  
D PM  but reported the identity o n ly  o f  the main isom er. In Table 1 the identities o f  
the other three isom ers are assum ed to be the sam e as those reported by Landry and 
Y ano. In other studies the com p osition  o f  D P G M E  w as not reported.
T he odor threshold for D P G M E  w as reported in a rev iew  to be 35  ppm  
( 2 1 0  m g /m ^) ( 4 4 ) .
T able 1. Composition o f  commercial DPGME (Dowanol ®  DPM).
Isomer0 Relative proportion (%)
GC-FIDfc GC-MSC
1 -{2-m elhoxy-1 -methylethoxy)-2-propanol 84.5 87.4
2-(2-m  ethoxy-1 -melhylethoxy)-l -propanol 0.5 or l.6 d 0.1 or 1.3*
2-(2-mcthoxy-2-methylethoxy)-1-propanol 0.5 or ].6d 0.1 or 1.3*
1 -(2-inethoxy-2-methy lethoxy)-2-propanol 13.0 11.2e
Purity (%) 99.2 >98
identity established with NMR (25)
^proportion and purity determined by GC-FID (25) 
^proportion determined by GC-MS (30)
. ^structure not identified 
^identity not reported
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3 USES AND OCCURRENCE
Propylene g ly co l ethers are used industrially as so lvents for paints, lacquers, resins, 
o ils  and fat. D PG M E  is often  used  in cosm etics (41). A bout 3 2 9 0 0 0  em p loyees  
(100000  o f  them  fem ales) are potentially exposed  to PG M E in the U nited States. 
A bout 3 0 6 0 0 0  em p loyees (36000  fem ales) are potentially exp osed  to PG M E A  and  
184000 (17000  fem ales) to D PG M E  (N ational occupational exposure survey, 
1981-1983: Estim ated total and fem ale em ployees, actual observation and trade- 
nam ed exposure to PGM E. U npublished provisional data as o f  January 1 ,1 9 9 0 .  
N IO SH , Cincinnati, Ohio).
A ccord ing to the Products R egister at the Sw edish  C hem icals Inspectorate, PG M E  
occurred in 421 chem ical products present on the Sw edish  market in July 1989  
(T able 2). T he estim ated  annual use w as 4 8 0 -5 8 0 0  tons. P G M E A  occurred in 187  
products (2 8 0 -4 5 0 0  tons/year) and D P G M E  in 123 products (2 4 0 -2 5 0 0  
tons/year).
T he use o f  propylene g ly co l ethers appears to have increased considerably from  
1985 to 1989. O ne important reason for the increase is probably the replacem ent o f  
ethylene g lyco l ethers by propylene g lyco l ethers because o f  the reproductive  
tox icity  associated  with the form er group o f  solvents.
The beta isom ers o f  the propylene g lyco l ethers w ere declared to be present in a few  
products only. A ccord ing to the register BPGME and BPG M EA occurred in 4  
products each in 1989 (Table 2). The estim ated annual quantity ranged betw een 9  
and 150 tons for BPGME. The beta isom ers are treated in this docum ent as they are 
present as im purities in technical PG M E and PG M EA .
T able 2. Occurrence ofpropylene glycol ethers in Swedish chemical products (source: 
U lf Rick, The Products Register, Swedish Chemicals Inspectorate).
3.1 Uses
Glycol ether October 1985 July 1989
numbed min* maxc number  ̂ min^ maxc
of products (ton/year) (ton/year) of products (ton/year) (ton/year)
PGME 112 90 290 421 480 5800
PGMEA 0 - - 187 280 4500
BPGME 0 - - 4 9 150
BPGMEA 0 - - 4 - -
DPGME 42 50 170 123 240 2500
“number of products in the register with a declared content of the compound 
^estimated minimum annual use Estimated maximum annual use
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3 .2  A m bient a ir  levels a t the w orkplace
O nly  a few  records o f  occupational exposure m easurem ents have been published.
S in ce 1985 the N orw egian N ational Institute o f  O ccupational H ealth has co llected  in 
a data base the results o f  their analyses o f  volatile organic com pounds in personal 
air sam ples (T ables 3 and 4). A s  o f  1988, 5 5 0 0  sam ples had been analyzed. PG M E  
w a s detected  in 6 87 , or 12 % o f  them . T he sam ple w ith the h ighest leve l o f  PG M E, 
1030 ppm , w as co llected  during so lvent c lean ing  in a paint factory. T he highest  
average lev e ls  w ere associated  with paint manufacturing., printing and silk screen 
printing. P G M E A  w as detected  in 2 6 0  sam ples, or 5 %. T he highest average lev e ls  
w ere m easured around metal production and air-craft lacquering. R elatively  low  
lev e ls  w ere m easured in silk screen printing. T he beta isom er o f  m ethoxypropanol 
w as detected  in 2 % , or 127 o f  the sam ples. Sam ples co llected  around  
m anufacturing o f  paint, m etal and plastics had average le v e ls  o f  2 - 3  ppm. The  
h ighest leve l o f  BPGM E, 14 ppm , w as associated  with clean in g  in a paint factory. 
T he other propylene g lyco l ethers d iscussed  in this docum ent w ere not identified. 
T hese data should be interpreted with caution, as the num ber o f  analyses aim ed at 
finding propylene g lyco l ethers is not docum ented. In addition, the detection lim its 
are not g iven  and m ay vary.
Peak le v e ls  o f  0 .5 -7  ppm  (2 -2 6  m g /m 3) PG M E  w ere reached in apartm ents 
painted w ith water-based alkyd and acrylate paints (23).
In a survey covering several work p laces parquet fitters in Finland w ere exp osed  to 
approxim ately  3 5 -3 9  ppm  PG M E  during undercoat varnishing and 1 0 -6 3  ppm  
during varnishing with urea-form aldehyde based products (R iita R iala, personal 
com m unication).
T able 3. Propylene glycol ethers found in 5500 personal air samples collected in 
Norway 1985-1988 (source: Per Einar Fjeldstad, Norwegian National Institute o f  
Occupational Health).
Glycol elher Number of samples with presence of glycol ether
> det. limit > 1 ppm > 5 ppm > 10 ppm > 50 ppm > 100 ppm
PGME 687 419 174 79 20 5
PGMEA 260 89 50 40 8 1




Standardized m ethods for sam pling and analysis o f  am bient air lev e ls  sp ecific  for  
propylene g ly co l ethers have not been published. H ow ever, the m ethods used for  
ethylene g lyco l ethers m ight be applicable. Sam ples are taken either actively  with  
adsorption tubes or p assive ly  with d iffu sive sam plers containing either activated  
charcoal or A m berlite X A D -7 . D iethyl ether or a m ixture o f  m ethanol and 
m eth ylen e ch loride is  used for desorption, and analysis is  m ade by gas  
chrom atography w ith flam e ionization  detection  (G C -F ID ) (2 , 5, 13). In the 
p resence o f  other gaseou s polar substances, for exam ple water vapor, the 
adsorption and/or desorption e ffic ien cy  m ay be reduced (36). Langhorst analyzed  
P G M E  in the range 0 .2 -3 0 0  ppm  and D P G M E  in the range 0 .7 -5 7  ppm  after 
adsorption on activated charcoal and desorption by a m ixture o f  water and carbon  
d isu lfid e . T he y ie ld  for PG M E  w as 9 6 - 9 9  %  in the so lven t phase and 1 .7 -3 .1  %  
in the aqueous phase; for D P G M E  y ie ld s w ere 7 9 - 8 4  %  and 9 - 1 4  %, resp ective ly  
(2 6 ).
Propylene g ly co l ether vapors m ay also be m onitored by infrared spectrophotom etry  
(2 4 , 51). T he detection  lim its for ethylene and d iethylene g lyco l ethers m onitored by  
this m ethod range from  0 .0 3 -0 .0 8  ppm  according to on e instrum ent m anufacturer 
(F oxboro, R edhill Surrey, Great Britain). A nother m anufacturer (BrUel & Kjaer, 
Naerum, D enm ark) states that its instrum ent, w hich is equipped with a 
photoacou stic  detector, has detection  lim its o f  0 .1 -0 .3  ppm  for various eth y len e  
g ly co l ethers. Fourier transform infrared (FTIR) spectrom etry m ay im prove  
resolution, com ponent identification and analytical sensitivity. Y in g  e t al. reported 
d etection  lim its o f  about 0 .0 1- 0.1 ppm  for various so lven t vapors m easured by  
FTIR w ith a spectral resolution  o f  2  cm -1 . T he detection  lim it for 2 -eth oxyeth an o l 
w a s 0 .0 1 2  ppm  (5 5 ).
3.3 Analytical methods for air monitoring
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T able  4. Job activities associated with exposure to propylene glycol ethers (source: Per 
Einar Fjeldstad, Norwegian National Institute o f  Occupational Health).









Paint manufacturing 1030 20 98 157
Printing 80 10 18 87
Silk screen printing 61 9 13 132
PGMEA
Metal production 103 18 33 21
Air-craft lacquering 91 12 19 83
Silk screen printing 12 0.9 1.9 94
fiPGME
Solvent cleaning 13.9 2.0 3.6 24
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4 TOXICOKINETICS
4 .1  U ptake
D u e to the solubility  o f  the propylene g lyco l ethers a high uptake m ay be expected  
for all routes o f  exposure. T he relative respiratory uptake in anesthetized  rats w as  
87  % for  P G M E  (exp osu re lev e l 1000  ppm ) and 85 % for P G M E A  (exposure  
lev e l 100 0  ppm ) (52). For com parison , the relative respiratory uptake o f  the  
eth y len e g ly co l ethers 2-b u toxyeth an ol, 2-eth oxyeth an o l, 2-e th o x y eth y l acetate, 
2-m eth o x y eth a n o l and 2 -p rop oxyeth y l acetate ranged betw een  5 0  and 7 9  %  in m an  
and d o g  (1 5 -1 8 ,  21 ).
T he blood/air partition coeffic ien t o f  PG M E  is  12400 according to o n e  study (20) 
and 403  according to another (52). The high affin ity  to  b lood  su ggests that 
pulm onary ventilation , and not the equilibration betw een air and b lood , is  the rate- 
lim iting  factor for the uptake o f  PG M E. T his hypothesis is  supported by  
experim ents in w hich the b lood  PG M E concentration in rats increased continuously  
during 6 hr o f  exp osu re to 3 0 0 -3 0 0 0  ppm  (35).
T he percutaneous uptake o f  neat PG M E in v itro  (isolated human epiderm is) o f
1.2  m g  cm _2 hr_1 ( 12 ) is  re la tive ly  h igh com pared w ith other organic so lven ts. 
A m o n g  the g ly co l ethers studied on ly  2 -m eth oxyeth an ol had a higher percutaneous 
uptake rate. N o  data regarding in v ivo  skin uptake o f  propylene g ly co l ethers w ere  
found in the literature. Skin uptake w as indirectly indicated by tox ic  e ffects  
observed  in rabbits and rats after derm al application o f  PG M E  and D P G M E  (40, 
4 8 ) .
4 .2  P ro b ab le  ro u tes  o f hu m an  exposure
T he propylene g ly co l ethers m ay enter the body by the respiratory as w ell as the 
derm al route. For D P G M E  w ith its low er vapor pressure the respiratory route m ay  
be o f  le ss  im portance relative to the derm al route. B oth exposure routes are o f  
special concern in cases o f  aerosol form ation during spray painting with products 
contain ing propylene g ly co l ethers.
4 .3  D is tr ib u tio n
P G M E  w as detected  in b lood  from  rats exp osed  for 6 hours to 3 0 0 -3 0 0 0  ppm  
(35); concentrations ranged from  1.2 to 2 3 .4  m M  (1 0 9 -2 1 1 3  Hg/g).
N o  studies on the distribution o f  propylene g ly co l ethers; in the body w ere found in  
the literature. The lo w  o liv e  o il/b lood  partition co effic ien t o f  0 .0 5 6  (20) suggests  
that PG M E  d oes not accum ulate in adipose tissue.
In a num ber o f  studies M iller and cow orkers have investigated the distribution o f
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radioactivity in rats fo llo w in g  oral administration or vapor exposure to 14C -lab eled  
PG M E  (31), P G M E A  (32 ), BPGM E (3 4 ) and D P G M E  (30). In general, m ajor  
fractions o f  the radioactivity rem aining in the body 48  hours after exposure w ere  
recovered in the skin and the liver. There w ere no indications o f  accum ulation o f  
radioactivity  in adipose tissue, testes or m ain body tissues.
4 .4  B io tra n s fo rm a tio n
T he m ajor m etabolic pathw ays o f  propylene g lyco l ethers can be sum m arized as 
fo llo w s: 1) acetate esters are rapidly hydrolyzed to the corresponding ether alcohol, 
2) ether a lcoh ols, both alpha and beta isom ers, are conjugated w ith sulphate and 
glucuronic acid , 3) beta isom ers, being primary a lcoh o ls, are a lso  o x id ized  to  
carb oxylic  acids, 4 ) alpha isom ers, being secondary a lcoh o ls, are a lso  ox id ized  to 
carbon d io x id e  after c lea v a g e  o f  the ether bond (Figures 1 -3 ) .
P G M E
W hen rats w ere g iven  an oral d ose  o f  14C -la b eled  PG M E  (1 m m ol/k g  body  
w eig h t), 11 % o f  the adm inistered radioactivity w as found  in the urine and 0.9 %  
in the fe c e s  w ithin 48  hours after the d osage. M ost (66 %) o f  the g iven  d o se  w as  
recovered  in the expired air. M ost o f  the exhaled  radioactivity (63  % )  w as carbon  
d iox id e. A fter a higher d ose  o f  PG M E  (8 .7  m m ol/kg) the recovery  in urine 
increased to 1 9 -2 5  % . T he predom inant urinary m etabolite w as the glucuronic acid  
conjugate o f  PG M E, fo llo w ed  by the sulphate conjugate, propylene g lyco l 
(1 ,2 -p ro p a n ed io l) and unchanged PG M E  (31). It is  know n from  previous studies  
that propylene g ly co l is  ox id ized  to lactic and pyruvic acids, and subsequently  
enters the normal carbohydrate m etabolism  o f  the body to finally  end up as carbon  
d iox id e  (42 , 4 3 , 54 ). T he m etabolism  o f  PG M E is dep icted  in Figure 1.
P G M E A
R ats g iven  an oral d o se  (8 .7  m m ol/k g  body w eigh t) o f  14C -la b e led  P G M E A  
excreted  2 4  %  o f  the radioactiv ity  in urine, 1.8 % in fe c e s , and 66 %  in exp ired  
air (64  % as carbon d iox id e) w ithin 4 8  hours. T he half tim e o f  the rad ioactivity  in 
the urine w as 5 .5  hr after an oral d ose and 7 .0  hr after 6 hr o f  exposure to  
3 0 0 0  ppm . T he urinary m etabolite pattern w as in agreem ent with that observed for  
PG M E  (32). T he m etabolism  o f  PG M E A  is sum m arized in F igure 1.
A cetate esters o f  aliphatic alcohols are rapidly hydrolyzed by en zym es in the 
respiratory ep ithelium , lungs, liver and blood  (10 , 53). PG M E A  in the body w ould  
therefore be rapidly converted to PG M E. A  com parison o f  the m etabolism  o f  
PG M E  (31) and P G M E A  (32) supports this hypothesis. H en ce, at equim olar d oses  
the tw o com pounds m ay be expected to act sim ilarly with respect to k inetics as w ell 
as toxicity . A t very high d oses o f  PG M E A , h ow ever, the acetic acid form ed in the 

















F ig u re  1. The metabolism o f  the alpha isomers o f  methoxypropanol and  
methoxypropyl acetate.
BPGME
Rats g iven  an oral d ose  (1 m m ol/k g  body w eight) o f  14C -la b eled  BPGM E excreted  
7 0  %  o f  the rad ioactiv ity  in urine, 1.6 % in fe c e s  and 16.7 % in expired  air 
(1 6 .6  %  as carbon d io x id e) w ithin  48  hours. A fter a h igher d o se  (8 .7  m m ol/k g)  
the recovery in urine increased to 77  % . T he m ajor m etabolite w as
2-m eth oxyp rop ion ic  acid. T he glucuronic acid conjugate and unchanged BPGME  
w ere a lso  found (34). T he m etabolism  o f  BPGM E is sum m arized in Figure 2.
DPGME
W hen rats w ere g iven  an oral d ose  (8.7  m m ol/k g  body w eigh t) o f  14C -lab eled  
D P G M E  6 0  % o f  the rad ioactivity  w as recovered in urine, 2 .7  %  in fe c e s  and
2 7 .2  % in expired air (2 6 .6  %  as carbon d iox id e) w ithin 48  hours. T he h a lf tim e  
o f  radioactivity in the urine w as 5 .9  hr. The predom inant urinary m etabolite w as 
dipropylene g ly co l, but sulphate and glucuronic acid  conjugates, propylene g ly c o l , 
PG M E and unchanged D PG M E  were a lso  identified (30). T he m etabolism  o f  
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F ig u re  2 . T he m e ta b o lism  o f  th e  b e ta  iso m ers  o f  m e th o x yp ro p a n o l a n d  
m eth o x yp ro p y l ace ta te .
4 .5  E lim in a tio n
In rats o f  both sex es exp osed  to 3 0 0 -3 OCX) ppm  PG M E for 6 hours the elim ination  
kinetics w ere nonlinear. A t a tenfold  increase in  exposure lev e l the b lood  lev e ls  
increased 2 0  tim es. T he h a lf tim e o f  the b lood  PG M E concentration w as 2 .4  hr after 
the low est exposure lev e l and 15.7 hr after the highest. A ssum ing a constant vo lu m e  
o f  distribution o f  0 . 9 1/kg body w eight, the total b lood  clearance o f  PG M E w as ca lcu ­
lated to 3.1 m lm in  - 1 kg-1 at the low est and 0.5  m lm in ' 1 kg-1 at the h ighest level. 
T he post exposure decay o f  blood  PG M E leve ls  fo llow ed  zero order rather than first 
order kinetics (35). T hese results indicate saturation o f  the PG M E m etabolism .
4 .6  B iological exposu re  in d ic a to rs
N o  studies on b io log ica l m onitoring o f  exposure to propylene g ly co l ethers are 
available.
U nchanged  PG M E  or D PG M E  as w ell as a num ber o f  m etabolites in urine and/or 
blood  are candidates for b io logica l exposure indicators. M orgott and N olan  
analyzed by gas chrom atography the parent com pound and the m etabolite  
1,2-p rop an ed io l in  rats exp osed  to PG M E  (35). U sin g  ion  ex c lu sio n
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chrom atography - m ass spectrom etry M iller and cow orkers identified  the sulphate 
and glucuronic acid conjugates o f  PG M E , 1 ,2-p ropanediol and unchanged PG M E  
in  the urine o f  rats g iven  high d o ses  o f  PG M E  or P G M E A  ( 3 1 ,3 2 ) .  R ats dosed  
w ith D P G M E  excreted  d ipropylene g ly co l, 1 ,2-p ropaned io l, PG M E , sulphate and 
glucuronic acid conjugates, and unchanged D P G M E  (30). R ats g iven  BPGME  
excreted  2-m eth oxyp rop ion ic  acid, BPG M E-glucuronide and unchanged BPGME
T he com pounds listed  above w ere detected in experim ental anim als after high doses  
o f  propylene g ly co l ether. T o  detect these com pounds at lev e ls  expected  after 
occupational exposure, m ore sen sitive  m ethods w ill probably be needed.
1-(2 -m etho xy-1  -m ethyl 
ethoxy)-2-propanol
















Figure 3. T he m e ta b o lism  o f  d ip ro p y le n e  g ly c o l m e th y l e th er.
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5 G E N E R A L  T O X I C O L O G Y
5.1 Toxic mechanisms and in vitro studies
The ethylene glycol ether 2-methoxyethanol is teratogenic and has testicular and 
hematologic effects. The adverse effects have been attributed to the major metabolite 
m ethoxyacetic acid (7 ,3 8 ,5 6 )  or to further metabolism o f  methoxyacetic acid (46). 
In parallel with the metabolism o f  2-methoxyethanol to yield methoxyacetic acid, 
BPGME is metabolized to 2-methoxypropionic acid. It might therefore be suspected 
that the toxicity o f these two glycol ethers would also be similar. Accordingly, 
BPGME (and BPGMEA) would have teratogenic, hematological and testicular 
effects. This hypothesis gained support in a study by Merkle e t  a l . ,  who found 
BPGMEA to be slightly teratogenic in the rat and more so in the rabbit (28).
PGMEA is rapidly hydrolyzed to PGME and acetic acid by carboxylases in the 
nasal mucosa (53). The liberated acetic acid may be responsible for the damage to 
the olfactory epithelium observed in laboratory animals exposed to PGMEA (32) 
(see Section 6.1).
Jackh e t  a l . investigated the cytotoxicity o f  various glycol ethers and their acid 
metabolites in Chinese hamster ovary cells without metabolic activation. The 
ethylene glycol ethers 2-methoxyethanol and 2-ethoxyethanol and the propylene 
glycol ethers PGME and BPGME exhibited similar cytotoxicity, with EC50 values 
(defined as the the concentration allowing 50 %  o f seeded cells to form colonies 
after 16 hr o f  incubation with the test substance) ranging from 0 .2  to 0.5 mmol/ml. 
Methoxypropionate (ECjq = 0.1 mmol/ml) was more cytotoxic than its parent 
compound BPGME (EC50 = 0.3 mm ol/m l) but less toxic than m ethoxy-, e th ox y-  
and butoxyacetate (E C ^  = 0 .0 4 -0 .05  mmol/ml), the oxidation products o f  the 
ethylene glycol ethers (22).
3-M ethoxypropionate, a structural isomer o f 2-methoxypropionate, retarded 
growth and produced abnormalities in post-implantation rat embryo cultures at 
concentrations o f 2 and 5 mM. Methoxyacetate and ethoxyacetate were more potent 
than 3-methoxypropionate, while the nonteratogenic butoxyacetate was less potent 
at the same concentrations (37).
5.2 Factors influencing toxicity
As the exposure level o f PGME increases from 300 to 3000 ppm, the elimination 
rate decreases in rats (see also Section 4.5). The decrease seem s to be due to 
saturation o f the O-demethylation capacity while conjugation increases in relative 
terms (35). Due to metabolic saturation, the relationship between ambient air 
exposure level and blood PGME concentration, and possibly also the toxic effects, 
will not be linear but curve upwards.
18
PGM E may induce its own metabolism in rats. Following 10 days o f  exposure at 
3000 ppm (6 hr/d) an increased elimination rate w as shown by lowered end-of- 
exposure blood levels (from 1816 to 1002 Jlg/g), shortened half time (from 15.7 to
9.7 hr) and increased blood clearance (from 0.5 to 0.8 m lm in ^ -k g -1 body 
weight) o f  PGME. Both liver weight and the amount o f  cytochrome P -4 5 0  in the 
liver increased significantly. In addition, hepatic microsomal aniline hydroxylase 
. and p-nitroanisole-O -dem ethylase activities doubled or tripled (35). Induction o f  
the metabolism o f  propylene glycol ethers is a possible explanation o f  the transient 
effects on the central nervous system, liver, urine, and blood chemistry (these 
effects are described in the follow ing section).
Sex differences in the metabolism o f  PGME have been observed in rats. The end- 
of-exposure concentration o f  PGME in blood was about 40  %  higher in male rats 
than in fem ale rats exposed to 3000 ppm for 6 hours. After 24 hr the blood PGME 
levels were nearly 8 times greater in males than in females. In addition, males had 
about 30 %  longer half time o f  PGME in blood, and their blood propylene glycol 
levels were approximately double those o f the females (35).
5.3 General effects
The propylene glycol ethers are o f  low  and approximately equal acute toxicity. The 
L D jq ranges from 4  to 14 g/kg body weight for all routes o f  administration (oral, 
intraperitoneal and dermal) except the intravenous in the mouse, rat, rabbit and dog 
(Table 5).
In amounts close to lethal doses in animals the propylene glycol ethers have a 
depressant action on the central nervous system and the heart and may produce eye, 
nose and lung irritation. Signs o f  intoxication included: anxiety, vomiting, diarrhea, 
dyspnea, ataxia, hypotension, ventricular and auricular arrhythmia, respiratory 
depression and narcosis (40, 45).
With repeated exposure o f  animals to sublethal doses o f  PGME or DPGME, the 
initial signs o f  intoxication gradually disappear. Initially, rats and rabbits exposed to 
PGME at 3000 ppm became sedated and lost weight. These effects disappeared 
gradually during continued exposure and were com pletely gone after 14 days (19, 
24, 29, 33, 40). Rats repeatedly exposed to DPGM E at 3 0 0 -4 0 0  ppm (7 hr/d) 
were also affected during the first w eeks o f  exposure but appeared normal thereafter 
(40).
PGME
A number o f  organs were examined for gross pathological or histopathological 
changes follow ing inhalation exposure o f rats and rabbits to 3000 ppm PGME for 
13 w eeks (6 hr/d, 5 d/wk). Apart from minor effects in som e organs, reported in 
the follow ing pages, no changes attributed to this treatment were observed (24).
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P G M E A
Various organs and tissues from rats and m ice o f  both sexes exposed to 3000 ppm  
PGM EA for two w eeks were investigated microscopically. N o adverse effects were 
observed, except in the nasal epithelium (discussed in Section 6.1) and kidneys 
(Section 6 .4) (32).
DPGME
Various organs from 10 rats and 7 rabbits o f each sex were examined for gross 
pathological or histopathological changes following inhalation exposure to 
200  ppm DPGM E for 13 w eeks (6 hr/d, 5 d/wk). There was no histopathological 
evidence o f  damage in any o f  the examined tissues, and no change in urine ketones 
w as observed (25).
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Table 5. Acute toxicity of propylene glycol ethers expressed as LD50 values (g/kg 
body weight).
Species Number of 
animals
Route of administration Reference
oral intra- intra- sub- dermal 
venous peritoneal cutaneous
PGME
mouse 5 females 
5 males
10.7 4.9 (50)









rat 5 females 
5 males
7.9 3.9 3.9 7.2 (50)
rabbit 4 males 12.9 (48)
rabbit 3 females 
3 males















rat 169 both sexes 5.1 (40)
rat 5 males 5.4 (48)
rabbit 4 females 9.5 (48)
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6 ORGAN EFFECTS
6.1 Skin and mucous membranes
PGME
In a series o f experiments Stewart and coworkers investigated the adverse effects o f  
PGME in male volunteers. An unspecified number o f subjects detected the odor o f  
PGME vapor in a truck cab at 10 ppm but not at 5 ppm. Exposure to 300 ppm for 
5 min produced mild irritation o f eyes, nose and throat. At 750 ppm the PGME 
vapor was judged to be extremely irritating (51).
The effects o f  PGME in males were further investigated in experimental chamber 
exposures. The effects studied in these experiments are listed in Table 6. One man 
exposed to 50 ppm experienced flushing o f the cheeks after 7 min in the exposure 
chamber and was not used in the follow ing experiments. Four o f  six males stated 
immediately upon exposure to 95 ppm PGME that the odor was too strong to be 
tolerated and wished to terminate the experiment. However, odor tolerance 
developed within 25 min. One o f the subjects complained o f mild eye irritation after 
one hour o f  exposure to 95 ppm, and two complained after tw o hours. A total o f  
23 men were exposed to 2 3 1 -2 4 9  ppm PGME for 1 -7  hr. After 15 to 30 minutes 
eight men experienced eye irritation, three had nose irritation, one had a headache 
and one was nauseated. After 45 to 60 minutes 20 o f the 23 males had developed  
eye irritation and increased blinking, 15 complained o f nose irritation, two o f throat 
irritation and one had a headache. Eight o f ten men remaining in the chamber after 2 
hr complained o f eye irritation and five had nasal irritation. O f the four subjects 
remaining in the chamber for 7 hr, all had eye irritation and lacrimation, but none o f  
them was still able to detect the odor o f  PGME (51).
In the last experiment two subjects were exposed to a PGME concentration steadily 
increasing from 1 to 2050 ppm over a 2-hr period. The subjects noted the odor at 
less than 25 ppm, reported objectionable odor at 50-75  ppm, light-headedness and 
mild eye irritation at 300-400  ppm, eye, nose and throat irritation at 500 ppm and 
lacrimation and rhinorrhea at 700 ppm. One o f the subjects became incapacitated by 
eye irritation at 1000 ppm and was removed from the chamber. The second subject 
stayed in the chamber until 2050 ppm o f PGME was reached. He experienced 
severe lacrimation, blepharospasm and throat irritation and was unwilling to breathe 
through his nose because o f pain. The nose and throat pain disappeared within 
15 min following exposure. The eye irritation disappeared in about 1 hr, while 
nasal congestion was present for 24 hr (51).
In a study o f the ability o f chemicals to cause injury to the rabbit eye PGME scored 
4 in one study and 3 in a later study. The injury was scored from 1 to 10 based on 
the amount and concentration o f  chemical needed to cause keratoconus, iritis, 
corneal opaqueness and corneal necrosis. The scores 3 and 4 indicate that 
instillation o f  0.1 and 0.02 ml, respectively, o f  undiluted PGME causes severe 
injury (8, 48).
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Table 6. Clinical and laboratory parameters investigated by Stewart et al. (51) in their 
studies on acute effects of PGME vapor. Various exposure protocols were used. One man 
was exposed to 47 ppm for 1 hr, six to 95 ppm for 3.5 hr and 23 men were exposed to 
231-249 ppm for 1-7 hr. Two men were exposed to a PGME concentration steadily 
increasing from 1 to 2050 ppm in 2 hr. One of these men terminated the experiment at 
1000 ppm. The effects are further described in Sections 6.1 and 6.8.
Parameter studied Effect observed Parameter studied Effect observed
Physical examination Subjective responses
Body temperature no Detection of odor yes
Blood pressure no Odor intensity yes
Pulse rate no Headache yes
Respiratory rate no Irritability yes
Vital capacity no Light-headedness yes
Tidal volume no Nausea yes
Electrocardiogram no Eye, nose or throat irritation yes
Sleepiness no
Blood analysis Speech difficulty no
Blood cell count no Chest discomfort no
Sedimentation rate no Abdominal pain no
Serum glutamic oxaloacetic transaminase no Loss of apetite no
Serum glutamic puryvic transaminase no
Lactic dehydrogenase no Neurological tests
Serum alkaline phosphatase no Modified Romberg yes
Blood urea nitrogen no Brake reaction-time no
Serum creatinine no Heel-to-toe no
Finger-to-nose no
Urine analysis Crawford manual dexterity no
24-hr creatinine excretion no Flannagan no
Urobilinogen no
Catecholamines no
PGME scored 2 on a 10-step scale with respect to skin injury. The scores 1 and 2 
correspond to no irritation and to the least visible capillary injection, respectively. A  
score o f  10 indicates necrosis from a 0.01 %  solution (48).
One drop o f  PGME placed in the rabbit eye for five consecutive days caused a mild 
transitory irritation o f  the conjunctiva. There was no cumulative effect and no 
indication o f  corneal injury (40). Gross and histological examination o f  the skin o f  
rabbits exposed daily by dermal application for up to 13 w eeks (5 d/wk), with 
doses between 1 and 10 ml PGME per kg body weight revealed som e animals with 
scaling and erythema. However, there was no significant difference between 
PGME-treated animals and controls treated with water (40).
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P G M E A
Degeneration o f  the olfactory epithelium was observed in three o f  five male rats and 
in one o f  five fem ale rats exposed to 3000 ppm PGM EA for tw o w eeks (6 hr/d;
5 d first w eek, 4 d second w eek). In m ice exposed to 300, 1000 or 3000 ppm at 
the same schedule this degeneration was observed to be dose-related. The authors 
suggested that the effect was related to acetic acid resulting from hydrolysis o f  
PGMEA in the nasal epithelium (32).
DPGME
The irritating concentration o f DPGM E in man was reported in a review paper to be 
7 4  ppm (450  m g/m 3), or about tw ice the odor threshold (44).
Application o f 0 .04  ml o f  a 20 % aqueous solution o f  DPGM E to one eye o f  each  
o f  ten human male volunteers caused a minor stinging sensation for 3 0 -4 5  sec, and 
was accompanied by slight excess lacrimation and blepharospasm for about 1 min. 
A mild injection o f  the conjunctival vessels and a minor increase in intraocular 
tension were observed during the first hour (6).
DPGM E scored 2 on a 10-step scale with respect to eye injury in the rabbit. This 
score means that 0.5 ml o f  undiluted PGME causes severe eye injury. DPGM E  
caused no skin irritation in rabbits (48).
One drop o f  DPGM E placed in the rabbit eye on each o f  five consecutive days 
caused a mild transitory irritation o f the conjunctiva. There was no cumulative effect 
and no indication o f  corneal injury (40).
In a more recent experiment, 0.1 ml o f  undiluted DPGM E instilled into the inferior 
conjunctival sac caused moderately severe conjunctoblepharitis in all six female 
rabbits. The effect peaked after about 6 hr and disappeared within a week. A  4 0  % 
aqueous solution o f  DPGM E produced mild conjunctival irritation and a 20 % 
solution was without effects. There was a dose-related increase o f  intraocular 
tension and corneal thickness in the exposed rabbit eyes (6).
N o  studies on BPGME or BPGMEA were found.
6.2 Respiratory system 
PGME
Rats exposed to 10000 ppm PGME for 6 hr developed microscopic changes reveal­
ing slight local irritation and congestion in the lungs (40). The same observation was 
made in rats exposed to 6000 ppm for 16 weeks and in a small number o f monkeys 
and rabbits exposed to 1500 ppm or more for 5 -2 9  weeks (see Table 10 for details). 
No effects on the lungs were seen in rabbits or monkeys exposed to 800 ppm (40).
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N o gross pathological or histopathological effects were seen in the lungs or 
respiratory tracts o f  rats and m ice o f  both sexes exposed to 3000 ppm PGME for 
tw o w eeks (6 hr/d; 5 d first w eek, 4  d second w eek) (29). A  13 -w eek  study with 
rats and rabbits o f  both sexes exposed to 300, 1000 or 3000 ppm (6 hr/d, 5 d/wk) 
w as also negative (24).
PGMEA
N o changes in lung weight, gross pathology or histology were observed in rats and 
m ice exposed to 3000 ppm PGM EA for 2 w eeks (6 hr per day) (32).
DPGME
Rats, rabbits, guinea pigs and m onkeys o f  both sexes were exposed to 
3 0 0 -4 0 0  ppm DPGM E for 26 -31  w eeks (7 hr/d, 5 d/wk). Judging by organ 
weight and macroscopic and histological examination , there were no effects on the 
lungs in any o f  the species studied (40).
H istological examination o f  lungs and trachea from nits and rabbits o f both sexes 
exposed to up to 200  ppm DPGM E for 13 w eeks (6  hr/d, 5 d/wk) revealed no 
exposure-related effects (25).
N o  studies on BPGME or BPGMEA were found.
6.3 Liver 
PGME
Stewart e t  a l. exposed a total o f  32 male volunteers to PGME vapor in various 
short-term (1 -7  hr) inhalation experiments at concentrations ranging from 47 to 
approximately 1000 ppm (see Section 6.1 and Tables 6 and 7 for details). A ll 
subjects had normal values with respect to clinical chemistry (Table 6), and there 
was no difference between preexposure and postexposure values (51).
Both the absolute and the relative liver weights o f male rats and the relative liver 
weights o f female rats and female mice were higher than that o f controls after two 
weeks o f exposure (6 hr/d; 5 d first week, 4 d second week) to 3000 ppm PGME.
Six weeks after termination o f the PGME exposure the liver weights had returned to 
normal. There were no treatment-related changes in either rats or m ice exposed to 
up to 3000 ppm PGME with respect to liver histology,, serum glutamic-pyruvic trans­
aminase activity, urea nitrogen, glucose, total protein, albumin, globulins or total 
bilirubin. Serum alkaline phosphatase activity was statistically significantly lower 
than controls (p<0.05) in male rats exposed to 3000 ppm and in female rats exposed  
to 300 ,10 00  or 3000 ppm (6 hr/d; 5 d first week, 4 d second week). According to 
the authors, however, these depressions were probably related to the nutritional 
status o f the animals (29).
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Rats exposed to 3000 ppm PGME for 13 w eeks (6 hr/d, 5 d/wk) exhibited small 
increases (6 to 8%) in liver weight relative to controls. Hepatocellular swelling  
without degenerative changes was observed in the female but not in the male rats. In 
addition, the fem ale rats exhibited slightly increased serum glutamic pyruvic 
transferase activities. Slightly elevated alkaline phosphatase activities (p<0.05) 
were observed in rabbits exposed to 3000 ppm PGME for 13 w eeks (6 hr/d,
5 d/wk). These enzym e acitivities were, however, not higher than values observed  
in control animals in recent studies in the same laboratory (24).
Miller and coworkers also observed increased liver w eights in rats o f  both sexes and 
hepatocellular swelling in female but not male rats exposed to 3000 ppm PGME for 
13 w6eks (6 hr/d, 5 d/wk). Clinical chemistry analyses were not conducted (33).
A series o f inhalation experiments (7 hr/d, 5 d/wk) was conducted by Rowe and co l­
leagues with PGME. Increased liver weights were observed in monkeys and rabbits 
after exposure to 1500 ppm and higher for 2 6 -29  weeks, in guinea pigs after ex­
posure to 6000 ppm for 16 weeks and in rats after exposure to 3000 ppm and higher 
for 17 weeks. M icroscopic examination revealed slight (unspecified) changes in the 
livers from female rabbits exposed to 1500 ppm or higher for 13-26  weeks and 
guinea pigs o f  both sexes exposed to 6000 ppm for 16 weeks. Only 3 o f 10 female 
and 6 o f 10 male rats survived exposure 6000 ppm for 17 weeks. Increased liver 
weights were observed in the surviving animals. Increased liver weights and un­
specified microscopic changes in the liver were also observed in male rats after 
exposure to 6000 ppm for 4 days (40).
P G M E A
In rats and m ice o f  both sexes exposed to 0, 300, 1000 or 3000 ppm PGM EA
6 hr/d for two w eeks (5 d first w eek, 4 d second w eek), liver weights were 
unaffected, except in female rats in the highest exposure group; these had a 
significantly higher mean relative liver weight compared to controls. However, the 
weight change was not accompanied by any other gross or histopathological 
finding. Further, clinical chemistry analyses —  serum glutamic-pyruvic 
transaminase and alkaline phosphatase activities, urea nitrogen, glucose, total 
bilirubin, total protein, albumin and globulins —  revealed no adverse effects (32).
D P G M E
Female guinea pigs and rabbits and monkeys o f both sexes exposed to 
3 0 0 -4 0 0  ppm DPGM E for 26-31  w eeks (7 hr/d, 5 d/wk) exhibited slight but 
definite changes o f granulation in the cytoplasm and numerous vacuoles in the liver 
cells. These changes were not seen in rats o f  either sex (40).
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There were no statistically significant hepatic effects in rats and rabbits o f  both 
sexes exposed to up to 200  ppm DPG M E for 13 w eeks (6 hr/d, 5 d/wk). The 
parameters investigated were liver weight and histology, alkaline phosphatase and 
serum glutamic pyruvic transaminase activities, serum proteins (total protein, 
albumin and globulin) and urobilinogen (25).
6.4 Kidneys 
PGME
Kidneys with a normal appearance by gross examination and normal blood urea 
levels were observed in male rabbits that survived 13 w eeks o f  daily (5 d/wk) 
dermal doses o f  2 ml (5 o f  6 survived), 4 ml (5 o f  7 survived) or 7 ml (1 o f  9 
survived) PGM E per kg body weight. Interstitial nephritis and tubular necroses 
were observed in 3 o f 19 male rabbits that died during 13 w eeks o f  exposure to 7 or 
10 ml kgr^d-1 (40). Other rabbits that died exhibited only a slight granular 
degeneration in the tubules.
Rats o f  both sexes exposed to 10000 ppm PGME (17 w eeks, 2 hr/d, 5 d/wk; or a 
single 6 -h r  exposure) and male rats and guinea pigs o f both sexes exposed to 
6000 ppm (16 weeks; 7 hr/d, 5 d/wk) had increased kidney w eights but normal 
blood urea levels, and the histological appearance o f the kidneys was normal (40).
There were no effects on absolute or relative weight, gross pathology or histology  
in the kidneys o f  rats and m ice exposed to 300, 1000 or 3000 ppm PGME for two 
w eeks (6 hr/d; 5 d first w eek, 4  d second week). At the highest exposure level o f  
3000 PGME urine pH was increased and there was a tendency to a decrease in 
specific gravity. The effects gradually regressed and had disappeared 6 w eeks after 
exposure (29). In a 13-w eek  study exposure o f  rats and rabbits to 100, 300 and 
3000 ppm (6 hr/d, 5 d/wk) had no effect. H ow ever elevated urine pH was 
observed in male rats after 4 weeks, but not after 12 weeks, o f  exposure to 
3000  ppm (24).
PGMEA
A ll five male and tw o o f five female rats exposed to 3000 ppm PGM EA for two 
weeks (6 hr/d) had slightly reticulated (pale, honeycombed) kidneys and a slight 
increase in the eosinophilic granularity o f  the proximal convoluted tubules o f  the 
kidneys. The effect was not seen in any sex o f  m ice after similar exposure. Other 
renal parameters, kidney weight and blood urea, were within normal limits (32).
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Kidneys with a normal appearance by gross examination, and normal blood urea 
levels were observed in all rabbits surviving 13 w eeks o f  daily (5 d/wk) dermal 
doses o f  1 ml (all 5 m ales survived), 3 ml (9 o f  11 males survived), 5 ml (6 o f  11 
m ales survived) or 10 ml (1 o f  7 males survived) DPGM E per kilogram o f body 
w eight (40).
Rats and rabbits o f  both sexes exposed to up to 200 ppm DPGM E for 13 w eeks 
(6 hr/d, 5 d/wk) showed no statistically significant effects compared to controls 
with respect to kidney weight and histology, urea nitrogen and urine specific 
gravity, but fem ale rabbits exposed to 200 ppm had 14 % higher relative kidney 
weight. However, both the relative and absolute kidney weights o f  the DPGME- 
treated animals were within the range o f  historical controls. A s there were no signs 
o f  nephrotoxicity, the increased kidney weights were thought to be unrelated to the 
exposure to DPGM E (25).
N o studies on BPGME or BPGMEA are reported.
6.5 Gastrointestinal tract
Apart from signs o f  irritation on the gastric epithelium following high oral doses o f  
PGME or DPGM E (40) no adverse effects on the gastrointestinal tract have been 
observed after exposure to PGME, PGMEA or DPGME.
N o studies on BPGME or BPGMEA are reported.
6.6 Circulatory system
PGM E or DPGM E (> 0.3 m l/kg body weight) intravenously administered to 
anesthetized dogs induced transitory changes in the electrocardiogram, accompanied 
by hypotension. Ventricular asystole and auricular fibrillation occurred at higher 
doses (0.8 m l/kg body weight). This effect persisted for as long as five minutes 
(45). N o reports mention any effects on the heart or blood circulation at lower 
exposure levels.
N o studies on PGM EA, BPGME or BPGMEA are reported.
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6 . 7  H e m a t o l o g i c a l  s y s te m
PGME
There were no treatment-related changes in packed cell volume, erythrocyte count, 
hem oglobin or total leukocyte count in rats o f  both sexes exposed to PGME at up to 
3000 ppm for a total o f  9 days (6 hr/d). The mean platelet counts were elevated, 
but this change was considered to be o f  uncertain toxicologic significance in v iew  o f  
the variability o f  this parameter in the control animals. There were no statistically 
significant changes in the animals in the recovery group, including platelet counts, 
when sacrificed 6  w eeks after termination o f exposure. N o hematological effects 
were observed in either male or female m ice (29).
White cell counts in female rats exposed to 300 ppm PGME for 13 weeks (6 hr/d,
5 d/wk) were reported to be higher than in controls. On the other hand, the white 
cell counts were reduced in the female rats exposed to 3000 ppm in the same experi­
ment. The significance o f these findings is difficult to evaluate since neither the num­
ber o f animals or the levels o f  significance are given. The investigators consider the 
deviations in white cell count to be sporadic occurrences unrelated to exposure. No  
other hematologic effects were found in either rats or rabbits (33).
Rats and rabbits o f  both sexes were exposed to 300, 1000 and 3000 ppm PGME  
for 13 w eeks (6  hr/d, 5 d/wk). N o hem atological effects (bone marrow, thymus 
and lymph node histology, packed cell volum e, erythrocyte count, hemoglobin, 
total and differential leukocyte count) were observed in either species (24).
PGMEA
There were no effects on thymus and spleen weights, histology o f  bone marrow or 
thymus or hematology parameters (not specified) in m ice and rats o f  both sexes 
exposed to 300, 1000 or 3000 ppm PGM EA for two w eeks (6 hr/d; 5 d first 
w eek, 4 d second w eek) (32).
BPGMEA
A 4 -w eek  inhalation study with BPGMEA in male Wistar rats showed no bone 
marrow effects. The highest exposure level was 2800 ppm (internal report by 
Klimisch e t  a l . 1984, cited by Merkle e t  a l . 1987 (28)).
DPGME
DPGM E has been suggested as one possible cause o f  bone marrow injury observed 
in seven lithographers working with multicolor offset and ultraviolet curing 
printing. Personal and area samples revealed air levels o f  0 .6 -6 .4  ppm DPGME. 
Neither benzene nor ethylene glycol monomethyl ether, known inducers o f  bone 
marrow injury, were found in the products used. G loves were used only  
intermittently and frequent and prolonged skin contact with wash solutions occurred 
during clean-up. The products used contained a number o f  other organic solvents,
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including ethylene glycol monoethyl ether, methyl ethyl ketone, and aromatic and 
halogenated hydrocarbons (9). Thus, exposure to ethylene glycol m onoethyl ether 
cannot be excluded as a cause o f bone marrow injury. In v iew  o f  the negative 
findings in animal experiments, it seems highly unlikely that DPGM E could cause 
the bone marrow injury observed in the lithographers.
There were no statistically significant hematologic effects in rats and rabbits o f  both 
sexes exposed to up to 200  ppm DPGM E for 13 w eeks (6 hr/d, 5 d/wk). The 
parameters investigated were bone marrow, thymus and lymph node histology, 
packed cell volum e, hemoglobin, erythrocyte count, total and differential leukocyte 
count and platelet count (25).
6.8 Central nervous system 
PGME
In a series o f experiments Stewart and coworkers investigated acute effects o f  
PGME vapor on male volunteers (see Section 6.1 and Tables 6 and 7 for details). 
There was no deterioration in vision, coordination, neurological responses or brake 
reaction time during 3.5 hr o f  exposure at 100 ppm and 7 hr o f  exposure at 
250 ppm. Two subjects were exposed to a PGME concentration rising steadily 
from 1 to 2050 ppm over a 2 -h r  interval. At 3 0 0 -4 0 0  ppm both subjects reported 
that they felt slightly light-headed. After one hour, when the concentration had 
reached 1000 ppm, one o f  the subjects was unable to perform a normal m odified  
Romberg test ( i.e . to balance on one foot with his eyes closed and both arms at his 
sides). He was then severely affected by eye, nose and throat irritation and was 
removed from the exposure chamber (irritant properties are described in Section 
6.1). After an additional hour in the chamber, when the concentration had reached 
2050 ppm, the second subject completed the tests with normal pre-exposure scores 
(51).
PGME vapor produced a transient nonspecific depression o f  behavior in female rats 
exposed at 5000  or 10000 ppm, but not at 2500 ppm (4 hr/d for 10 days). The 
substance was judged to be ineffective with regard to the conditioned avoidance- 
escape behavior o f  the rats (14). In a number o f rat experiments a transient sedative 
effect o f  PGME has been noted during exposure at 3000 ppm. The effect 
disappeared after 1 -2  weeks. Less pronounced sedation has been noted in mice, 
guinea pigs and rabbits (19, 24, 29, 33).
N o weight changes or histopathological deviations were observed in the brains o f  
rats and rabbits o f  both sexes exposed to 3000 ppm PGME for 13 w eeks (6 hr/d, 
5 d/w k) (24).
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D P G M E
N o adverse effects (weight change and histology) were observed in the brains o f  
rats and rabbits o f  both sexes exposed to 200 ppm DPG M E for 13 w eeks (6 hr/d, 
5 d /w k) (25).
6.9 Peripheral nervous system
There are no reports on any effects on the peripheral nervous system.
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7 IMMUNOTOXICITY AND ALLERGY
D P G M E
Undiluted DPGM E was applied to the backs o f  200 subjects (100 men and 100 
wom en) and allowed to remain in contact with the skin for five days. Three w eeks 
later the compound was applied again to the backs o f the same subjects and allowed  
to remain for 48 hr. In a second experiment, DPGM E was tested in 50 subjects (25  
men and 25 women). This time the material was applied to the backs o f  the subjects 
and allowed to remain for 4 -8  hr every other day until 10 applications had been  
made. After three w eeks DPGM E was reapplied for 2 4 -4 8  hr. N one o f  the subjects 
exhibited any evidence o f irritation or sensitization at any time (40). Although these 
experiments were not conducted in accordance with modem test protocols, the 
results seem to indicate that DPGM E is not a skin sensitizer.
There are no studies on the other propylene glycol ethers.
8 MUTAGENICITY, GENOTOXICITY 
P G M E
The genetic toxicology o f  the glycol ethers was reviewed by McGregor in 1984. 
PGME was negative in a bacterial mutation test with S . ty p h im u r iu m ,  with and 
without metabolic activation. Furthermore, PGME did not increase unscheduled 
D N A  synthesis in hepatocytes, nor the number o f chromosomal aberrations in 
Chinese hamster ovaiy cells (unpublished report cited by McGregor (27)).
There is no information about the other propylene glycol ethers.
M ost studies have been conducted with 2-m ethoxyethanol and 2-ethoxyethanol. 
Although a few  tests have yielded positive responses the available evidence is 
sufficient to conclude that, in general, the glycol ethers are not strongly genotoxic
(27).
9 CARCINOGENICITY




There were no changes in testis weight or histology in rats or m ice exposed to 
PGM E containing 4 %  beta isom er at levels up to 3000  ppm for tw o w eeks 
(6  hr/d; 5 d first w eek, 4 d second w eek) (29). A  second study, extended to 13 
w eeks o f  exposure at levels up to 3000 ppm PGM E containing 1.8%  BPGME, 
and including rabbits, was also negative (24).
Exposure o f  pregnant Wistar rats to PGME (content o f  BPGME not specified) at 
200  and 600 ppm for 6 hr per day from day 6 through 17 o f  gestation had no 
effect on litter size, pup weight, viability or external appearance. Male rats exposed  
for 10 days at the same levels showed no reduction in testes w eight or atrophy o f  
the seminiferous tubules, an effect seen after exposure to 2-m ethoxyethanol (11).
Pregnant rats and rabbits were exposed (6 hr/d) to 5 0 0 ,15 0 0  and 3000 ppm PGME 
containing 1.32 % BPGME during organogenesis (days 6 through 15 and 6 through 
18, respectively). There were mild signs o f maternal toxicity, lethargy and decreased 
weight gain in both species and fetal toxicity and delayed sternal ossification in rats 
at 3000 ppm, but no signs o f teratogenic effects at any exposure level (19).
BPGME
M iller and coworkers state that no testicular effects were seen in rats and mice after 
a 2 -w eek  exposure to a PGME mixture containing up to 18 % beta isomer. The 
highest exposure concentration was 3000 ppm. N o further details o f these 
unpublished experiments were given (34).
Results from an unpublished pilot study with BPGME demonstrated the same 
embryotoxic profile in the rat as BPGMEA (see below). The details o f  the pilot 
study are not given (28).
3 -  Methoxypropionic acid, a structural isomer o f  2-m ethoxypropionic acid, the 
com m on metabolite o f  BPGME and BPGMEA, retarded growth and caused 
abnormalities in post-implantation rat embryo cultures (see Section 5.1 for details).
BPGMEA
Pregnant Wistar rats exposed to 110, 550 or 2700 ppm BPGMEA for 6 hr/d on 
gestation days 6 -1 5  exhibited maternal toxicity at the 550 ppm level and maternal 
and fetal toxicity at the 2700 ppm level. The effects reported include slight 
sedation, pulsative respiration, decreased body weight gain (p=0.01), reduced 
uterus w eight (p=0.05 at 2700 ppm), reduced number o f  live fetuses at 2700 ppm 
(p=0.05), weights o f  female and male fetuses at 2700 ppm (p=0.01), increased per­
centage o f dead implantations at 2700 ppm (p=0.05) and increased percentage o f  
fetuses with anomalies at 2700 ppm (not significant). At the highest exposure level
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of 2700 ppm BPGMEA a few  fetuses had skeletal anomalies o f the thoracic 
vertebrae— dumbbell-shaped or bipartite notches o f the cartilage. At 550 ppm one 
fetus had bipartite notches. These anomalies were not seen in the control group and 
at the lowest exposure level and were interpreted as signs o f a slight teratogenic 
effect (28).
The teratogenicity was more pronounced in Himalayan rabbits. These were exposed  
to 0 ,3 6 ,1 4 5  or 550 ppm (6 hr/d) BPGMEA from gestation days 6 through 18. There 
were no signs o f maternal toxicity except a slight decrease in body weight gain at 
day 18 o f gestation (p=0.05) which had disappeared by day 29. Fetal toxicity was 
manifested as increased percentage o f  dead implantations at 550 ppm (p=0.05), 
reduced female fetuses weight at 145 ppm (p=0.05) and reduced female and male 
fetuses weight at 550 ppm (p=0.01). N o anomalous fetuses were seen at 0  and 145 
ppm. At 36 ppm 3 anomalies (diaphragmatic hernia, absent gall bladder and 
scoliosis) were observed in 65 fetuses. At 550 ppm all 62 fetuses from 13 litters had 
anomalies. These anomalies included: anarsacra (1 fetus), cleft palate (3 fetuses), her­
nia umbilicalis (2 fetuses), digit anomalies (17 fetuses), internal hydrocephalus 
(1 fetus), heart defects (4 fetuses), hydroureter (2 fetuses) and sternal anomalies (53 
fetuses) (28).
Dermal exposure o f  rabbits to 1000 and 2000 mg/kg BPGMEA from gestation days 
6 through 18 did not produce any maternal or fetal effects (28).
A 4 -w eek  inhalation study with BPGMEA in male Wistar rats showed no testicular 
effects even at the highest dose level o f  2800 ppm. The details o f  the experiment 
have not been published (28).
DPGME
There were no changes in testes weight or testicular histology in rats or rabbits 
exposed to 15, 50  or 200  ppm DPGM E for 13 w eeks (6 hr/d, 5 d/wk) (25).
There are no reports o f  teratogenic effects o f  DPGME.
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11 DOSE-EFFECT AND DOSE-RESPONSE 
RELATIONSHIPS 
11.1 Short-term exposure
T a b le  7. D o se-e ffec t re la tionsh ips f o r  sho rt-term  in ha la tion  expo sures to  P G M E .




2050 1 man 1 to 2050 in 2 hr (51) severe lacrimation and blepharospasm, pain and congestion of nose
1000 2 men 1 to 2050 in 2 hr (51) severe eye irritation in 1 man
750 ? men 5 min, single (51) extremely irritating
700 2 men 1 to 2050 in 2 hr (51) lacrimation, rhinorrhea
300 ? men 5 min, single (51) irritation of eyes, nose and throat
240 23 men 1-7 hr, single (51) irritation of eyes, nose and throat
95 6 men 3.5 hr, single (51) strongly objectionable odor initially, odor tolerance within 25 min, slight eye irritation 
in 2 men after 2 hr
47 1 man 1 hr, single (51) flushing of cheeks after 7 min
10 ? men 5 min, single (51) odor detected
5 ? men 5 min, single (51) odor not detected
M onkey
10000 1 male 6 hr, single (40) CNS depression, eye and nasal irritation
Rabbit
15000 8 both sexes 4-7 hr, single (40) CNS depression, unconsciousness, death
10000 8 both sexes 4-7 hr, single (40) CNS depression
3000 33 females 6 hr/d, d 6-18 of gestation (19)
CNS depression, decreased weight 
gain, no embryotoxic or teratogcnic effects
G uinea pig
15000 45 both sexes 6-10 hr, single (40) CNS depression, unconsciousness, death
M ouse
3000 5 females 
5 males
6 hr/d, 2 wk (29) CNS depression, increased liver weight in females
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Table 7 (continued). Dose-effect relationships for short-term inhalation exposures to
PGME (selected data).
Exposure Number of Exposure Reference Effects
(ppm) animals schedule
R at
15000 40 both sexes 2-8 hr, single (40) CNS depression, unconsciousness, death
15000 75 both sexes 1 hr, single (40) CNS depression
10000 105 both sexes 3-8 hr, single (40) CNS depression, unconsciousness, death
10000 15 females 
15 males
6 hr, single (40) increased liver, kidney and lung weight, lung irritation
10000 5 males 2 hr, single (40) increased liver weight
10000 50 both sexes 1.5-2 hr, single (40) CNS depression
7000 40 both sexes 4-6 hr, single (40) CNS depression, unconsciousness, death
7000 30 both sexes 3 hr, single (40) CNS depression
6000 10 males 7 hr/d, 4 d in 5 d (40) 1 died, increased liver and kidney weights, 
changes in liver and lung histology
5000 8-10 females 4 hr/d, 2 wk (14) transient CNS depression, no effect on 
conditioned avoidance-escape behavior
3000 10 males 7 hr, single (40) no observed effects
3000 28 females 6 hr/d, (19) CNS depression, decreased weight gain,
d 6-15 of gestation delayed stemebral ossification, no 
embryotoxic or teratogenic effects
3000 5 females 
5 males
6 hr/d,
5+4 d in 11 da
(29) CNS depression, increased liver weight, 
decreased urine specific gravity, increased 
urine pH, elevated platelet count, lowered 
alkaline phosphatase activity
1000 5 females 
5 males
6 hr/d,
5+4 d in 11 da
(29) lowered alkaline phosphatase activity in 
females
600 20 females 6 hr/d, (11) d 6-17 of gestation
no effect on offspring
600 10 males 6 hr/d, 10 d (11) no effect on testicles or hematology
300 5 females 
5 males
6 hr/d,
5+4 d in 11 da
(29) lowered alkaline phosphatase activity
a5 d of exposure first week, 4 d second week, 2 d interruption during weekend
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Table 8. Dose-effect relationships for short-term inhalation exposures to PGMEA.
Exposure Number of Exposure Reference Effects
(ppm) animals schedule
R at
3000 5 females 6 hr/d, 2 wk (32) increased liver weight in females,
5 males 5+4 d in 11 dfl changes in kidney histology, degeneration of 
olfactory epithelium
1000 idem idem (32) degeneration of olfactory epithelium
300 idem idem (32) no observed effects
M ouse
3000 idem idem (32) degeneration of olfactory epithelium
1000 idem idem (32) no observed effects
300 idem idem (32) no observed effects
a5 d of exposure first week, 4 d second week, 2 d interruption during weekend
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Rabbit, inhalation exposure (ppm)
550 15 females 6  hr/d, (28) d 6-18 of gestation
slightly reduced maternal weight gain, reduced fetal body weight, increased number of dead implantations, anomalies in all 63 fetuses
145 15 females idem (28) no observed maternal effects, reduced fetal weight
36 15 females idem (28) no observed maternal effects, anomalies in 3 of 65 fetuses
Rat, inhalation exposure (ppm)
2710 25 females 6  hr/d, (28) d 6-15 of gestation CNS depression, reduced maternal weight gain, reduced uterus weight, reduced fetal body weight, increased number of dead implantations, vertebral fusion defects
550 25 females idem (28) CNS depression, reduced maternal weight gain
1 1 0 25 females idem (28) no observed maternal or fetal effects
Rabbit, dermal exposure (mg-kg~l-dl)
2 0 0 0 16 females daily, (28) d 6-18 of gestation no observed maternal or fetal effects
1 0 0 0 15 females idem (28) no observed maternal or fetal effects









74 not given not given (1 ) irritation
35 not given not given 0 ) odor threshold
Rat
500 9 males 7 hr, single (40) CNS depression
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1 1 . 2  L o n g - t e r m  e x p o s u r e









1 0 0 0 0 1 females
2  males 4 hr/d, 5-13 wk (40) CNS depression, decreased final body weight, increased liver weight, changes in liver and lung histology
3000 2  females 7 hr/d, 29 wk (40) increased liver weight, changes in liver and 
lung histology
1500 1 female 7 hr/d, 29 wk (40) increased liver weight, changes in lung histology
800 1 female 
1 male 7 hr/d, 29 wk (40) no observed effects
Rabbit
6000 1 female 7 hr/d, 16 wk (40) CNS depression, decreased weight gain, increased liver and lung weight, changes in lung histology
3000 7 females 
6  males 6  hr/d, 13 wk
(24) CNS depression first 2 wk, increased alkaline phosphatase activity
3000 ? 6  hr/d, 13 wk (33) no observed effects
3000 1 female 
1 male 7 hr/d, 26 wk (40) increased liver weight, changes in liver (female) sind lung (male) histology
1500 2  females 
2  males 7 hr/d, 26 wk (40) increased liver weight, changes in liver and lung histology in females
1 0 0 0 7 females 
6  males 6  hr/d, 13 wk (24) no observed effects
800 2  females 
1 male 7 hr/d, 26 wk (40) no observed effects
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Table 11 (continued). Dose-effect relationships for long-term inhalation exposures









6000 5 females 5 males
7 hr/d, 16 wk (40) CNS depression, decreased body weight, increased liver and kidney weight, changes in liver and lung histology
3000 8  females 
8  males 7 hr/d, 26 wk
(40) no observed effects
1500 idem idem (40)
Rat
no obseived effects
1 0 0 0 0 5 females 5 males
2  hr/d, 17 wk (40) increased liver and kidney weight
1 0 0 0 0 idem 1 hr/d, 15 wk (40) CNS depression
1 0 0 0 0 idem 0.5 hr/d, 15 wk (40) no observed effects
6000 1 0  females 
1 0  males 7 hr/d, 16 wk (40) 7 females and 4 males died, CNS depression, increased liver weight, increased kidney weight in males
3000 2 0  females 
2 0  males
7 hr/d, 28 wk (40) CNS depression first week, increased liver weight
3000 1 0  females 
1 0  males 6  hr/d, 13 wk
(24) CNS depression first wk, increased liver weight, hepatocellular swelling in females, increased serum glutamic pyruvic transaminase activity in females, increased urine pH after 4 wk in males
3000 ? 6  hr/d, 13 wk (33) CNS depression first wk, increased liver weight, reduced white cell count in females, hepatocellular swelling in females
1500 2 0  females 
2 0  males
7 hr/d, 28 wk (40) no observed effects
1 0 0 0 1 0  females 
1 0  males
6  hr/d, 13 wk (24) no observed effects
1 0 0 0 ? 6  hr/d, 13 wk (33) no observed effects
300 ? 6  hr/d, 13 wk (33) increased white cell count in females
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300-400 1 female 
1 male 7 hr/d, 31 wk (40) changes in liver histology
Rabbit
300-400 2  females 
2  males 7 hr/d, 31 wk (40) changes in liver histology
2 0 0 7 females 7 males 6  hr/d, 13 wk (25) increased kidney weight in females
50 idem idem (25) increased body and kidney weight in females
15 idem idem (25) no observed effects
Guinea pig
300-400 5 females 7 males 7 hr/d, 26 wk (40)
Rat
changes in liver histology in females
300-400 17 females 13 males 7 hr/d, 28 wk (40) CNS depression first week, increased liver weight
2 0 0 1 0  females 
1 0  males 6  hr/d, 13 wk (25) no observed effects
50 idem idem (25) no observed effects
15 idem idem (25) no observed effects
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1 2 RESEARCH NEEDS
The irritant property o f  propylene glycol ethers to man is described in only one 
paper, and for PGM E only (51). This effect needs to be studied in more detail and 
in the other propylene glycol ethers as well.
Only one study concerning the reproductive toxicity o f  the beta isomers was found 
in the scientific literature (28). The study dealt with the effects o f BPGMEA in 
female rats and Himalayan rabbits. There is a need for additional investigations 
involving BPGME, male reproductive toxicity o f  both beta isomers and testing in 
other animal species.
The toxicokinetics o f the propylene glycol ethers have not been studied in humans. 
Such studies are valuable in order to assess respiratory and dermal uptake, 
distribution, metabolism and excretion. The possibility o f  dose-dependent kinetics 
in man should be investigated, as this has been observed for PGME in laboratory 
animals (35). Dermal uptake may contribute largely to the body burden o f  propylene 
glycol ethers. Methods for biological monitoring are therefore needed. The acid 
metabolite o f  BPGME, 2-m ethoxypropionic acid, is a strong candidate for 
biological monitoring o f exposure to BPGME for the following reasons:
2-m ethoxypropionic acid is closely related to the teratogenic potential o f  BPGME, it 
is to a large extent excreted in urine, and it probably has a long urinary half time.
To make possible toxicokinetic studies and to develop methods for biological 
monitoring sensitive analytical methods for the propylene glycol ethers and their 
metabolites in biological material will have to be developed.
13 DISCUSSION AND EVALUATION
The five propylene glycol monoalkyl ethers reviewed here are all o f  low acute 
toxicity. The main effect exerted at high doses is depression o f  the central nervous 
system. This effect has been clearly observed in animals exposed to PGME at 
3000 ppm or more (14, 19, 24, 29, 40), to BPGMEA at 550 ppm or more (28), 
and to DPGM E at 3 00 -4 00  ppm (40), but not at lower exposure levels. In the 
DPGME experiment a mist was present in the exposure chamber, and the internal 
dose may have been higher due to dermal deposition and uptake. One man acutely 
exposed to about 1000 ppm PGME exhibited a tendency to CNS effects, but 
exhibited no effects at lower exposure levels (51). There are no signs o f  subacute or 
chronic organ specific damage at levels below 1500 ppm PGME, 1000 ppm 
PGM EA and 3 00 -4 00  ppm DPGME. Furthermore, there are no indications o f  
mutagenicity or genotoxicity from any o f  the five glycol ethers, although such 
effects have only been studied to a limited extent. No carcinogenicity studies are 
reported. The alpha isomers o f PGME and PGMEA, as well as DPGM E, seem to 
lack reproductive toxicity. The critical effect o f these three compounds appears to be 
irritation to the eyes and mucous membranes. Two o f six men experienced eye, 
nose and throat irritation after 2 hr o f exposure to 95 ppm PGME (51).
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The beta isomer of PGMEA is embryotoxic and teratogenic in laboratory animals
(28). The effects were seen in the offspring of rats after exposure at 2710 but not at 
550 ppm and in rabbits at 550 but not at 145 ppm. Considering the metabolism of 
BPGMEA, it is very likely that 6 PGME is also teratogenic. The common metabolite 
of BPGME and BPGMEA is 2-methoxypropionic acid. The structural isomer
3-methoxypropionic acid caused growth retardation and abnormalities in post­
implantation rat embryo cultures (37). These observations are analogous to those 
made for methoxyacetic acid, common metabolites of 2 -methoxyethanol and 
2 -ethoxyethyl acetate (7, 38,56). Thus, the critical effect of BPGME and BPGMEA 
appears to be the teratogenic potential. The teratogenic potential of beta isomers 
present in technical PGME and PGMEA must be kept in mind, and these impurities 
should be monitored and kept as low as possible.
14 SAMMANFATTNING
Arbete och Hàlsa 1990:32, sid 1-47.
Kritisk genomgâng och vàrdering av den litteratur som àr relevant som underlag for 
faststallande av hygieniskt gransvârde for propylenglykol monometyleter och 
propylenglykolmonometyleteracetat inklusive deras betaisomerer, samt 
dipropylenglykolmonometyleter. Rekommendation av de effekter (irritation och 
reproduktionsstôming) som kan làggas till grund for ett sâdant stàllningstagande.
56 referenser.
Nyckelord: dipropylenglykolmonometyleter, hygieniskt gransvârde, irritation,
1 -m etoxi-2-propanol, 2 -m e to x i-1 -propanol, 1 -m etoxi--2-propy lacetat,
2 -m e to x i-1 -propy lacetat, 1 - (  2 -m e to x i-1 -m ety  letoxi)-2-propanol, 
propylenglykolmonometyleter, propylenglykol monometyleteracetat, 
reroduktionsstôrning, yrkesmàssig exponering.
15 SUMMARY
Arbete och Hàlsa 1990:32, p. 1-47.
Survey o f  the literature on propylene glycol monomethyl ether, propylene glycol 
monomethyl ether acetate, including their beta isomers, and dipropylene glycol 
monomethyl ether. The document is to be used as background for discussion o f  
occupational exposure limits. The effects irritation and reproductive toxicity are 
recommended to be used in this discussion. 56 references.
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occupational exposure, occupational exposure limits, propylene glycol methyl ether, 
propylene glycol methyl ether acetate, reproductive toxicity
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